Modified Acarbose Pentasaccharide

Modified Acarbose Pentasaccharide is a synthetic analog of acarbose, a pseudotetrasaccharide. This compound is a pentasaccharide, suggesting a modification or extension of the acarbose structure. It is being investigated as a potential pharmaceutical chemical, likely functioning as an inhibitor of alpha-glucosidase and alpha-amylase enzymes. Its anticipated mechanism of action involves delaying the digestion and absorption of complex carbohydrates in the gastrointestinal tract, thereby reducing postprandial blood glucose spikes, similar to its parent compound, acarbose. It is considered a research compound for potential use in managing type 2 diabetes.